drugset / Trial / NCT04729244

The Study of Hemp Oil CBD for Evaluation of Efficacy and Safety in Treatment of Pain, Anxiety and Insomnia Management

NCT04729244 ↗

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The investigators are looking to conduct a study looking at the effects of cannabidiol (CBD) from Hemp Oil in patients with Chronic pain, anxiety and insomnia. It is believed that CBD will improve pain anxiety and sleep quality and reduce opioid use. The study will last a total of 4 weeks and involve onsite visits in addition to weekly pain assessments.

Timeline

Start
2021-09-01
Primary completion
2021-11-01
Completion
2022-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator CBD Unknown 50 mg Topical